Enhancing opioid overdose education and naloxone distribution through pharmacist-led community outreach

View at publisher Summarise with VIRAT
Authors: Evan G. Adintori, Thao Pham, Samuel R. Beckerman, Jeremie Aviado, Jennifer Ting-Chan, Ruth Pichaj, Patty Nogueda, Karen de Guzman-Dunn, Alison Birnie, Tommy Mai
Cited by: 0
References: 4

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The rise in fentanyl-related overdoses in Los Angeles County over the last decade underscores the urgent need for initiatives to expand naloxone access and educate bystanders on naloxone use. Between 2016 and 2022, the incidence of fentanyl-related overdose outcomes in Los Angeles County increased sharply, with the number of deaths rising by 1,652% (from 109 to 1,910), emergency department (ED) visits by 833% (from 133 to 1,241), and hospitalizations by 387% (from 102 to 497).1 Naloxone, an opioid antagonist, is over 90% effective when administered promptly and can be delivered by laypersons or first responders. To broaden community-level access and mitigate opioid-related mortality, the California Department of Healthcare Services (DHCS) and the Substance Abuse and Mental Health Services Administration have implemented programs to distribute naloxone to eligible organizations. At Huntington Hospital, a multidisciplinary team combined with community outreach to enhance public education on opioid overdose prevention and increase access to naloxone among at-risk populations.

Fields of Study & Subjects

Opioid Use Disorder Treatment Substance Abuse Treatment and Outcomes Poisoning and overdose treatments

Publication details

Journal / source
American Journal of Health-System Pharmacy
Volume
83
Issue
16
Pages
818–821
Publication date
21 March 2026
Language
EN